4.6 Article

Subthalamic Single Cell and Oscillatory Neural Dynamics of a Dyskinetic Medicated Patient With Parkinson's Disease

期刊

FRONTIERS IN NEUROSCIENCE
卷 14, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fnins.2020.00391

关键词

Parkinson's disease; subthalamic nucleus; levodopa; dyskinesia; single unit activity; local field potentials

向作者/读者索取更多资源

Single cell neuronal activity (SUA) and local field potentials (LFP) in the subthalamic nucleus (STN) of unmedicated Parkinson's disease (PD) patients undergoing deep brain stimulation (DBS) surgery have been well-characterized during microelectrode recordings (MER). However, there is limited knowledge about the changes in the firing patterns and oscillations above and within the territories of STN after the intake of dopaminergic medication. Here, for the first time, we report the STN single cell and oscillatory neural dynamics in a medicated patient with idiopathic PD using intraoperative MER. We recorded LFP and SUA with microelectrodes at various depths during bilateral STN-DBS electrode implantation. We isolated 26 neurons in total and observed that tonic and irregular firing patterns of individual neurons predominated throughout the territories of STN. While burst-type firings have been well-characterized in the dorsal territories of STN in unmedicated patients, interestingly, this activity was not observed in our medicated subject. LFP recordings lacked the excessive beta (8-30 Hz) activity, characteristic of the unmedicated state and signal energy was mainly dominated by slow oscillations below 8 Hz. We observed sharp gamma oscillations between 70 and 90 Hz within and above the STN. Despite the presence of a broadband high frequency activity in 200-400 Hz range, no cross-frequency interaction in the form of phase-amplitude coupling was noted between low and high frequency oscillations of LFPs. While our results are in agreement with the previously reported LFP recordings from the DBS lead in medicated PD patients, the sharp gamma peak present throughout the depth recordings and the lack of bursting firings after levodopa intake have not been reported before. The lack of bursting in SUA, the lack of excessive beta activity and cross frequency coupling between HFOs and lower rhythms further validate the link between bursting firing regime of neurons and pathological oscillatory neural activity in PD-STN. Overall, these observations not only validate the existing literature on the PD electrophysiology in healthy/medicated animal models but also provide insights regarding the underlying electro-pathophysiology of levodopa-induced dyskinesias in PD patients through demonstration of multiscale relationships between single cell firings and field potentials.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia

Benjamin J. Dorfman, Joohi Jimenez-Shahed

Summary: Deutetrabenazine is effective in reducing dyskinesia in TD, but ongoing studies are exploring drug selection and cost-effectiveness among existing VMAT2 inhibitors. Other areas of investigation include novel anti-dyskinetic agents and the use of deep brain stimulation.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2021)

Article Engineering, Biomedical

Ensemble deep model for continuous estimation of Unified Parkinson's Disease Rating Scale III

Murtadha D. Hssayeni, Joohi Jimenez-Shahed, Michelle A. Burack, Behnaz Ghoraani

Summary: This study developed a novel algorithm using wearable technology to continuously estimate the severity of Parkinson's disease at home. The algorithm was successful in estimating PD severity scores without requiring patients to perform specific tasks, showing potential for effective disease management.

BIOMEDICAL ENGINEERING ONLINE (2021)

Article Engineering, Biomedical

Device profile of the percept PC deep brain stimulation system for the treatment of Parkinson's disease and related disorders

Joohi Jimenez-Shahed

Summary: Recent advancements in software and hardware in the field of deep brain stimulation (DBS) have led to the development of devices from three manufacturers. The Percept (TM) PC platform offers unique sensing and diary functions for refining therapeutic stimulation and tracking symptoms. Future work is needed to demonstrate the clinical utility and added value of using sensing to optimize DBS therapy.

EXPERT REVIEW OF MEDICAL DEVICES (2021)

Review Clinical Neurology

The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient Selection Present and Future

Davide Martino, Wissam Deeb, Joohi Jimenez-Shahed, Irene Malaty, Tamara M. Pringsheim, Alfonso Fasano, Christos Ganos, Winifred Wu, Michael S. Okun

Summary: The selection of patients with Tourette syndrome for deep brain stimulation surgery relies on 5 fundamental pillars, including tic severity, treatment failure, stability of comorbid psychiatric disorders, and an 18-year age limit. Future advances should focus on consensus-based definitions of treatment failure, stability of comorbid behavioral issues, and use of international registry data to identify predictors of positive response to DBS.

NEUROLOGY (2021)

Article Biology

Electroceutically induced subthalamic high-frequency oscillations and evoked compound activity may explain the mechanism of therapeutic stimulation in Parkinson's disease

Musa Ozturk, Ashwin Viswanathan, Sameer A. Sheth, Nuri F. Ince

Summary: Therapeutic high-frequency stimulation induces high-frequency oscillations similar to those observed with pharmacological treatment, along with evoked compound activity. The interaction between stimulation pulse and the phase of ECA affects the degree of enhancement in HFO power. High-frequency STN-DBS tunes neural oscillations to their healthy state, and the stimulation frequency can be inferred from the phase of ECA waveforms of individual subjects.

COMMUNICATIONS BIOLOGY (2021)

Article Clinical Neurology

North American survey on impact of the COVID-19 pandemic shutdown on DBS care

Mustafa S. Siddiqui, Joohi Jimenez-Shahed, Zoltan Mari, Benjamin L. Walter, Sol De Jesus, Fedor Panov, Jason M. Schwalb, Michele K. York, Harini Sarva, John M. Bertoni, Neepa Patel, Lin Zhang, James McInerney, Joshua M. Rosenow

Summary: The initial COVID-19 pandemic shutdown caused the cancellation of elective surgeries in most of the USA and Canada. This survey aimed to understand the impact of the shutdown on deep brain stimulation (DBS) practices in North America. The results showed that the pandemic-related shutdown led to significant changes in DBS practices in almost all North American sites that participated in the survey. This information could help in developing future contingency plans to reduce patient delays in care under similar circumstances.

PARKINSONISM & RELATED DISORDERS (2021)

Article Clinical Neurology

Healthcare resource utilization and device-aided therapy discussions with eligible patients across the Parkinson's disease continuum: Revelations from the MANAGE-PD validation cohort

Hubert H. Fernandez, Per Odin, David G. Standaert, Tove Henriksen, Joohi Jimenez-shahed, Sharon Metz, Ali Alobaidi, Connie H. Yan, Pavnit Kukreja, Juan Carlos Parra, Jorge Zamudio, Koray Onuk, Jack Wright, Angelo Antonini

Summary: This study categorized Parkinson's disease patients using MANAGE-PD and examined their quality of life, healthcare resource utilization, and discussions about device-aided therapies. The findings showed that patients with poorly controlled symptoms and eligible for device-aided therapies had higher burden on healthcare resources but a significant portion did not discuss device-aided therapies with providers.

PARKINSONISM & RELATED DISORDERS (2023)

Review Clinical Neurology

Effective Management of OFF Episodes in Parkinson's Disease: Emerging Treatment Strategies and Unmet Clinical Needs

Nbaa Masood, Joohi Jimenez-Shahed

Summary: Motor complications and the lack of disease modifying therapy counterbalance the discovery of levodopa as the cornerstone of PD treatment. Pathological changes in the striatum lead to OFF episodes caused by non-physiologic stimulation of dopamine receptors. Current research focuses on optimizing dopaminergic stimulation and implementing rescue therapies.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2023)

Meeting Abstract Clinical Neurology

Long-Term Treatment With Deutetrabenazine (DTBZ) Is Associated With Continued Improvement in Tardive Dyskinesia (TD): Results From the Completed, 3-year Open-Label Extension (OLE) Study

R. Hauser, H. Barkay, H. Fernandez, S. Factor, J. Jimenez-Shahed, N. Gross, L. Marinelli, A. Wilhelm, M. Gordon, J. M. Savola, K. Anderson

MOVEMENT DISORDERS (2020)

Meeting Abstract Clinical Neurology

Directional versus omnidirectional Deep Brain Stimulation: Results of a Multi-Center Prospective Blinded Crossover Study

Leonard Verhagen Metman, Jan Vesper, Pablo Mir, Matthew Brodsky, Sergiu Groppa, Ramiro Alvarez, Andrew Evans, Marta Blazquez Estrada, Sean Nagel, Witold Libionka, Julie Pilitsis, Monica Poetter-Nerger, Winona Tse, Leonardo Almeida, Nestor Tomycz, Joohi Jimenez-Shahed, Fatima Carrillo, Christian Hartmann, Florence Defresne, Edward Karst, Binith Cheeran, Alfons Schnitzler

NEUROLOGY (2020)

Meeting Abstract Clinical Neurology

Effect of Deutetrabenazine on Metabolic Parameters in the Treatment of Tardive Dyskinesia

Joohi Jimenez-Shahed, Hadas Barkay, Karen E. Anderson, Hubert H. Fernandez, Stewart A. Factor, Robert A. Hauser, Maria Wieman, Mark Forrest Gordon, Juha-Matti Savola

NEUROLOGY (2020)

Meeting Abstract Clinical Neurology

Clinical and neuropsychological correlates of the TETRAS score in DBS patients

Steven Bellows, Hannah Combs, Joohi Jimenez-Shahed

NEUROLOGY (2020)

Meeting Abstract Clinical Neurology

Directional deep brain stimulation in subthalamic nucleus for Parkinson's disease: results of a multicenter, prospective, blinded, crossover study

A. Schnitzler, P. Mir, M. Brodsky, L. Verhagen, S. Groppa, R. Alvarez, A. Evans, M. Blazquez Estrada, S. Nagel, J. Pilitsis, M. Poetter-Nerger, W. Tse, L. Almeida, N. Tomycz, J. Jimenez-Shahed, F. Carrillo, C. J. Hartmann, S. J. Groiss, F. Defresne, E. Karst, B. Cheeran, J. Vesper

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Meeting Abstract Clinical Neurology

Study design and rationale for an international study of DBS for movement disorders

A. Schnitzler, S. Groppa, A. Fasano, J. Ostrem, J. Pilitsis, F. Phibbs, K. Lyons, J. Jimenez-Shahed, N. Pouratian, J. Neimat, F. Defresne, E. Karst, B. Cheeran, R. Pahwa

EUROPEAN JOURNAL OF NEUROLOGY (2020)

暂无数据